Live

Tariffs latest: Trump says he's 'waiting' for China to call as negotiation push takes shape

Shenzhen CNY

Henan Shuanghui Investment & Development Co.,Ltd. (000895.SZ)

Compare

27.25

+0.57

+(2.14%)

At close: 3:04:36 PM GMT+8

Walgreens, CVS, & US drugmakers make big moves: What to know

Walgreens (WBA) stock is rising after the company reported better-than-expected second quarter earnings while preparing for privatization. Yahoo Finance Senior Health Reporter Anjalee Khemlani highlights the company's cost management strategy, CVS's (CVS) leadership changes amid similar challenges in the retail drug sector, and moves by US drug makers, like Merck (MRK), Johnson & Johnson (JNJ), and Eli Lilly (LLY), as they prepare for incoming tariffs. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video 33 minutes ago

WBA

MRK

CVS
Trump tariffs pose significant profit risk to Walmart

Walmart could be walloped in a worst-case tariff scenario.

Yahoo Finance 2 hours ago

WMT

LEVI

TGT
China tariffs, earnings, Small Business Optimism: What to Watch

Market Domination Overtime host Julie Hyman outlines what investors are watching on Tuesday, April 8. According to President Trump, China has until midnight on Tuesday to rescind its 34% retaliatory tariff in order to avoid an additional 50% tariff from the US. Tilray (TLRY) is set to report quarterly results before the opening bell, while Cal-Maine (CALM) will announce earnings after the closing bell. The market will get some Federal Reserve commentary from San Francisco Fed president Mary Daly and some fresh economic data with the Small Business Optimism Index to be released in the morning. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 15 hours ago

CALM

TLRY
Broadcom stock rises on $10B buyback plan

Shares of Broadcom (AVGO) rose in after-hours trading after the chip giant announced a share repurchase plan of up to $10 billion. Market Domination Anchor Julie Hyman and Slatestone Wealth chief market strategist Kenny Polcari, host of Trader Talk, discuss the breaking news in the video above. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 17 hours ago

AVGO
Stock market racing to price in a 'lost year' for corporate profits

The profit outlook for businesses has dimmed considerably post Trump tariff news.

Yahoo Finance 23 hours ago

GAP

MSFT

NVDA
President orders CFIUS review of U.S. Steel, Nippon Steel agreement

In an order published by White House, President Donald Trump stated in part: “On January 3, 2025, President Biden issued an order prohibiting the acquisition of United States Steel Corporation by Nippon Steel (NPSCY) Corporation, Nippon Steel North America, Inc., and 2023 Merger Subsidiary… In that order, President Biden reserved the right of the President ‘to issue further orders with respect to the Purchasers or U.S. Steel (X) as shall in my judgment be necessary to protect the national securi

TipRanks 1 minute ago

X

NISTF

NPSCY
Walgreens Boots Alliance, Inc. (WBA): Jim Cramer Says “Zombie Firm” No More – Can Private Equity Save Walgreens?

We recently published a list of Jim Cramer’s Game Plan: 10 Stocks in Focus. In this article, we are going to take a look at where Walgreens (NASDAQ:WBA) stands against other stocks in Jim Cramer’s focus. On Friday, Jim Cramer, the host of Mad Money, commented on the current state of the markets as he […]

Insider Monkey 12 minutes ago

WBA
Walgreens Boots Alliance Q2 Profit Falls 47.5%, Suspends Guidance On Pending Private Equity Deal

Walgreens Boots Alliance Inc (NASDAQ: WBA) on Tuesday reported second-quarter sales of $38.59 billion, up 4.1% year over year (+4.7% on constant currency), beating the consensus of $38 billion, reflecting sales growth in the U.S. Retail Pharmacy and International segments. Adjusted operating income was $785 million compared to $900 million a year ago, reflecting lower U.S. retail sales in the current quarter and sale-leaseback gains in the year-ago quarter, partly offset by cost savings within U

Benzinga 41 minutes ago

WBA
Levi Strauss Stock Rallies; CEO Says Tariff Price Hikes Will Be ‘Surgical’

Levi Strauss Chief Executive Michelle Gass said the jeans maker will be “surgical” with any price hikes, rather than make across-the-board changes in response to tariffs. The company has created a task force to look at tariff-mitigation strategies, including cost cutting, wringing concessions from suppliers and consumer price increases. "We believe the brand has pricing power," Gass said.

The Wall Street Journal 55 minutes ago

LEVI
Why New AI Winners Marvell Technology, Credo Technology, and Nebius Group Plunged in March

Both Marvell and Credo reported earnings early in the month, and both actually reported fairly good results. Marvell had perhaps the most interesting earnings release of these stocks during March. Both figures came in ahead of analyst expectations.

Motley Fool 1 hour ago

MRVL

CRDO
Here’s Why ClearBridge Dividend Strategy is Expecting Considerable Revenue Growth From CVS Health Corporation (CVS)

ClearBridge Investments, an investment management company, released its “ClearBridge Dividend Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The ClearBridge Dividend Strategy proved resilient and delivered positive returns despite a 4.3% decline in the benchmark S&P 500 Index. Despite increased caution over the economy and markets, the firm […]

Insider Monkey 1 hour ago

CVS
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks 1 hour ago

CVS
Want Better Returns? Don't Ignore These 2 Computer and Technology Stocks Set to Beat Earnings

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Zacks 1 hour ago

SMCI
These Stocks Are Moving the Most Today: Apple, Nvidia, Broadcom, Humana, CVS, Tesla, Super Micro, Marvell, and More

Apple stock rises after a three-day stretch that has seen shares of the iPhone maker tumble 19%, Broadcom announces a new buyback program of $10 billion, and CVS Health and Humana jump as Medicare boosts payment rates.

Barrons.com 1 hour ago

AVGO

NVDA

TSLA
Levi's Stock Rises as Firm Says Tariff-Fueled Price Changes Would Be 'Surgical'

Shares of Levi Strauss rose Tuesday, a day after the denim giant reported better-than-expected first-quarter profit and gave a relatively upbeat outlook on the Trump administration's new tariffs.

Investopedia 2 hours ago

LEVI
Walgreens Sales Rise on U.S. Retail Pharmacy Segment Growth

Walgreens Boots Alliance posted higher sales in its latest quarter on growth in retail-pharmacy sales in the U.S., in one of the last quarterly reports the company will publicly file ahead of its transition to a private company.

The Wall Street Journal 2 hours ago

WBA
Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health

WASHINGTON, D.C., April 08, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the signing of a Patent License Agreement with Yale School of Medicine and Yale School of Public Health to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. Tafenoquine is not currently appr

GlobeNewswire 2 hours ago

SXTP

SXTPW
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.

CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options, today announced that they have signed a Non-Binding Letter of Intent contemplating a potential business combinatio

GlobeNewswire 2 hours ago

ONCO
Shareholder-Approved Merger with Verde Bioresins, Inc. Progressing Towards Close

Nxu continues to work towards imminent completion of merger with Verde Bioresins, Inc.MESA, Ariz., April 08, 2025 (GLOBE NEWSWIRE) -- Nxu, Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company focused on energy storage and charging solutions for the infrastructure we need to power our electrified future, today announced it is progressing towards closing its merger with Verde Bioresins, Inc. (“Verde”). On February 11, 2025, approximately 99% of the votes cast by Nxu’s sharehol

GlobeNewswire 2 hours ago

NXU
CVS Health Appoints Former UPS And Pepsi Exec As Finance Chief, Stock Soars

CVS Health Inc (NYSE:CVS) on Tuesday named Brian Newman as executive vice president and chief financial officer designate, effective April 21. He will succeed current chief financial officer Tom Cowhey, who will transition as a strategic advisor to president and chief executive officer David Joyner, effective May 12. Newman was most recently executive vice president and chief financial officer of United Parcel Service Inc (NYSE:UPS). Also Read: FTC Pauses Lawsuit Against CVS, Cigna, UnitedHealth

Benzinga 2 hours ago

CVS

PEP

Performance Overview

Return	000895.SZ	SSE Composite Index (000001.SS)
YTD	+4.97%	-6.15%
1-Year	+7.59%	+3.23%
3-Year	+17.46%	-3.27%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

Henan Shuanghui Investment & Development Co.,Ltd. (000895.SZ)

Related News

Walgreens, CVS, & US drugmakers make big moves: What to know

Trump tariffs pose significant profit risk to Walmart

China tariffs, earnings, Small Business Optimism: What to Watch

Broadcom stock rises on $10B buyback plan

Stock market racing to price in a 'lost year' for corporate profits

President orders CFIUS review of U.S. Steel, Nippon Steel agreement

Walgreens Boots Alliance, Inc. (WBA): Jim Cramer Says “Zombie Firm” No More – Can Private Equity Save Walgreens?

Walgreens Boots Alliance Q2 Profit Falls 47.5%, Suspends Guidance On Pending Private Equity Deal

Levi Strauss Stock Rallies; CEO Says Tariff Price Hikes Will Be ‘Surgical’

Why New AI Winners Marvell Technology, Credo Technology, and Nebius Group Plunged in March

Here’s Why ClearBridge Dividend Strategy is Expecting Considerable Revenue Growth From CVS Health Corporation (CVS)

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Want Better Returns? Don't Ignore These 2 Computer and Technology Stocks Set to Beat Earnings

These Stocks Are Moving the Most Today: Apple, Nvidia, Broadcom, Humana, CVS, Tesla, Super Micro, Marvell, and More

Levi's Stock Rises as Firm Says Tariff-Fueled Price Changes Would Be 'Surgical'

Walgreens Sales Rise on U.S. Retail Pharmacy Segment Growth

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health

Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.

Shareholder-Approved Merger with Verde Bioresins, Inc. Progressing Towards Close

CVS Health Appoints Former UPS And Pepsi Exec As Finance Chief, Stock Soars

Performance Overview